Clinical Epidemiologic Profile of a Cohort of Post–Kala-Azar Dermal Leishmaniasis Patients in Bihar, India

Vidya Nand Rabi Das Rajendra Memorial Research Institute of Medical Sciences (ICMR), Agamkuan, Patna, Bihar, India

Search for other papers by Vidya Nand Rabi Das in
Current site
Google Scholar
PubMed
Close
,
Alok Ranjan Rajendra Memorial Research Institute of Medical Sciences (ICMR), Agamkuan, Patna, Bihar, India

Search for other papers by Alok Ranjan in
Current site
Google Scholar
PubMed
Close
,
Krishna Pandey Rajendra Memorial Research Institute of Medical Sciences (ICMR), Agamkuan, Patna, Bihar, India

Search for other papers by Krishna Pandey in
Current site
Google Scholar
PubMed
Close
,
Dharmendra Singh Rajendra Memorial Research Institute of Medical Sciences (ICMR), Agamkuan, Patna, Bihar, India

Search for other papers by Dharmendra Singh in
Current site
Google Scholar
PubMed
Close
,
Neena Verma Rajendra Memorial Research Institute of Medical Sciences (ICMR), Agamkuan, Patna, Bihar, India

Search for other papers by Neena Verma in
Current site
Google Scholar
PubMed
Close
,
Sushmita Das Rajendra Memorial Research Institute of Medical Sciences (ICMR), Agamkuan, Patna, Bihar, India

Search for other papers by Sushmita Das in
Current site
Google Scholar
PubMed
Close
,
Chandra S. Lal Rajendra Memorial Research Institute of Medical Sciences (ICMR), Agamkuan, Patna, Bihar, India

Search for other papers by Chandra S. Lal in
Current site
Google Scholar
PubMed
Close
,
Naresh K. Sinha Rajendra Memorial Research Institute of Medical Sciences (ICMR), Agamkuan, Patna, Bihar, India

Search for other papers by Naresh K. Sinha in
Current site
Google Scholar
PubMed
Close
,
Rakesh B. Verma Rajendra Memorial Research Institute of Medical Sciences (ICMR), Agamkuan, Patna, Bihar, India

Search for other papers by Rakesh B. Verma in
Current site
Google Scholar
PubMed
Close
,
Niyamat A. Siddiqui Rajendra Memorial Research Institute of Medical Sciences (ICMR), Agamkuan, Patna, Bihar, India

Search for other papers by Niyamat A. Siddiqui in
Current site
Google Scholar
PubMed
Close
, and
Pradeep Das Rajendra Memorial Research Institute of Medical Sciences (ICMR), Agamkuan, Patna, Bihar, India

Search for other papers by Pradeep Das in
Current site
Google Scholar
PubMed
Close
Restricted access

Post–kala-azar dermal leishmaniasis (PKDL) has important public health implications for transmission of visceral leishmaniasis (VL). Clinical and epidemiologic profiles of 102 PKDL patients showed that median age of males and females at the time of diagnosis was significantly different (P = 0.013). A significant association was observed between family history of VL and sex of PKDL patients (χ2 = 5.72, P < 0.01). Nearly 33% of the patients showed development of PKDL within one year of VL treatment. The observed time (median = 12 months) between appearance of lesions and diagnosis is an important factor in VL transmission. A significant association was observed between type of lesions and duration of appearance after VL treatment (χ2 = 6.59, P = 0.001). Because PKDL was observed during treatment with all currently used anti-leishmanial drugs, new drug regimens having high cure rates and potential to lower the PKDL incidence need to be investigated.

Author Notes

*Address correspondence to Alok Ranjan, Rajendra Memorial Research Institute of Medical Sciences, Agamkuan, Patna 800007, Bihar, India. E-mail: aranjan@yahoo.com

Authors' addresses: Vidya Nand Rabi Das, Krishna Pandey, and Naresh K. Sinha, Division of Clinical Medicine, Rajendra Memorial Research Institute of Medical Sciences, Agamkuan, Patna, Bihar, India, E-mails: drvnrdas@yahoo.com, drkrishnapandey@yahoo.com, and naresh_kumarsinha@yahoo.com. Alok Ranjan, Department of Epidemiology and Biostatistics, Rajendra Memorial Research Institute of Medical Sciences, Agamkuan, Patna, Bihar, India, E-mail: aranjan30@yahoo.com. Dharmendra Singh, Sushmita Das, and Pradeep Das, Division of Molecular Biology, Rajendra Memorial Research Institute of Medical Sciences, Agamkuan, Patna, Bihar, India, E-mails: singhd72@yahoo.co.in, sushmita.de2008@gmail.com, and drpradeep.das@gmail.com. Neena Verma, Division of Pathology, Rajendra Memorial Research Institute of Medical Sciences, Agamkuan, Patna, Bihar, India, E-mail: verma_neena@yahoo.com. Chandra S. Lal, Division of Biochemistry, Rajendra Memorial Research Institute of Medical Sciences, Agamkuan, Patna, Bihar, India, E-mail: drcslal@sify.com. Rakesh B. Verma and Niyamat A. Siddiqui, Department of Biostatistics, Rajendra Memorial Research Institute of Medical Sciences, Agamkuan, Patna, Bihar, India, E-mails: rbihariverma@yahoo.com and niyamatalisiddiqui@yahoo.com.

  • 1.

    Zijlstra EE, Musa AM, Khalil EA, El-Hassan IM, El-Hassan AM, 2003. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis 3: 8798.

  • 2.

    Ramesh V, Mukherjee A, 1995. Post kala-azar dermal leishmaniasis. Int J Dermatol 34: 8591.

  • 3.

    Zijlstra EE, El-Hassan AM, Ismail A, Ghalib HW, 1994. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and sub-clinical infection and post kala-azar dermal leishmaniasis. Am J Trop Med Hyg 51: 826836.

    • Search Google Scholar
    • Export Citation
  • 4.

    Manson-Bahr PE, Bell DR, 1987. Manson's Tropical Diseases. 19th edition. London: Bailliere Tindall/ELBS, 87113.

  • 5.

    World Health Organization, 1984. The leishmaniases. Report of the WHO Expert Committee. World Health Organ Tech Rep Ser 701: 1140.

  • 6.

    Sen Gupta PC, 1968. Leishmaniasis in India. J Med Assoc India 50: 3436.

  • 7.

    Addy M, Nandi A, 1992. Ten years of kala-azar in West Bengal. Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Paraganas? Bull World Health Organ 70: 341346.

    • Search Google Scholar
    • Export Citation
  • 8.

    Thakur CP, Kumar A, Mitra G, Thakur S, Sinha PK, Das P, Bhattacharya SK, Sinha AK, 2008. Impact of amphotericin B in the treatment of kala-azar on the incidence of PKDL in Bihar, India. Indian J Med Res 128: 3844.

    • Search Google Scholar
    • Export Citation
  • 9.

    Thakur CP, Kumar K, 1992. Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes. Ann Trop Med Parasitol 86: 355359.

    • Search Google Scholar
    • Export Citation
  • 10.

    Desjeux P, 2001. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 95: 239243.

  • 11.

    Dinesh DS, Kar SK, Kishore K, Palit A, Verma N, Gupta AK, Chauhan DS, Singh D, Sharma VD, Katoch VM, 2000. Screening sandflies for natural infection with Leishmania donovani using a non-radioactive probe based on the total DNA of the parasite. Ann Trop Med Parasitol 94: 447451.

    • Search Google Scholar
    • Export Citation
  • 12.

    Salotra P, Singh R, 2006. Challenges in the diagnosis of post kala-azar dermal leishmaniasis. Indian J Med Res 123: 295310.

  • 13.

    ICDDRB, 2007. Post kala-azar dermal leishmaniasis: new observations challenge previous assumptions. Health Sci Bull 5: 612.

  • 14.

    Brahmachari UN, 1992. A new form of cutaneous leishmaniasis, dermal leishmanoid. Ind Med Gaz 57: 125127.

  • 15.

    Thakur CP, Kumar M, Mishra BN, Pandey AK, 1988. Rationalization of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomized study. BMJ 296: 15571561.

    • Search Google Scholar
    • Export Citation
  • 16.

    World Health Organization, 1990. Control of leishmaniasis. World Health Organ Tech Rep Ser 739: 1158.

Past two years Past Year Past 30 Days
Abstract Views 110 110 8
Full Text Views 375 124 0
PDF Downloads 78 10 0
 
Membership Banner
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save